🟢 Strong Evidence
The UK National Health Service (NHS) has announced the introduction of two rapid diagnostic tests for endometriosis, a chronic gynaecological condition affecting an estimated 1.5 million women in the UK according to the Endometriosis UK charity. The new tests aim to significantly reduce diagnostic delays, which currently average 7–10 years in the United Kingdom, as reported by the NHS in its clinical commissioning guidance. These developments represent a meaningful shift toward earlier detection and faster access to treatment for a condition that has historically been underdiagnosed and mismanaged.
Key takeaways
- Two new rapid diagnostic tests for endometriosis will be available on the NHS, addressing a diagnostic bottleneck that has affected millions of UK women
- Current diagnostic delays average 7–10 years in the UK, according to NHS data, often leaving patients undertreated during their reproductive years
- These point-of-care tests could enable earlier identification and faster treatment initiation, potentially improving quality of life and fertility outcomes
- Implementation across primary and secondary care settings will require training and standardisation to ensure equitable access nationwide
A decade-long diagnostic gap
Endometriosis—a condition in which tissue similar to the uterine lining grows outside the uterus—affects approximately 1 in 10 women of reproductive age globally, according to the World Health Organization. In the UK, diagnostic delays have been a persistent clinical and public health problem. The NHS has documented that patients typically wait 7–10 years between symptom onset and confirmed diagnosis, during which time they often receive ineffective or suboptimal management.
These delays impose substantial costs on both patients and the healthcare system. Untreated or under-treated endometriosis can lead to chronic pain, reduced fertility, work disability, and diminished quality of life. Studies published in peer-reviewed journals have documented the psychological and economic burden of prolonged diagnostic uncertainty.
Endometriosis diagnostic delay: a global burden
Average time from symptom onset to confirmed diagnosis, selected countries
Source: Endometriosis UK, NHS clinical commissioning guidance, 2024 | Georgian Medical Journal News
Two new tests with rapid turnaround
The two rapid tests announced by the NHS are designed to be deployed in both primary care (general practice) and secondary care (hospital) settings. These point-of-care or laboratory-based assays aim to provide diagnostic confirmation within weeks rather than the current multi-year pathway, which typically requires imaging, laparoscopy, or histological confirmation.
While the NHS announcement does not specify the exact nature of these tests, rapid endometriosis diagnostics under development globally typically rely on blood biomarkers or non-invasive imaging protocols that can stratify risk and identify probable cases. The introduction of these tools is expected to reduce unnecessary delays and enable clinicians to initiate evidence-based treatment—including hormonal therapies, pain management, and surgical options—much earlier in the patient journey.
Early diagnostic confirmation of endometriosis can allow women to access appropriate treatments during their reproductive years, potentially preserving fertility and reducing the cumulative burden of untreated disease.
— Endometriosis UK, clinical guidance
Implementation challenges and next steps
Rolling out new diagnostic tests across the NHS’s diverse primary and secondary care landscape presents logistical and training challenges. Healthcare professionals in general practice and hospital laboratories will require standardised protocols and competency validation to interpret results and counsel patients appropriately. Additionally, equitable access across all regions of England, Scotland, Wales, and Northern Ireland will be essential to prevent widening of existing diagnostic disparities.
The NHS has committed to supporting implementation through clinical networks and continuing professional development. Success will depend on integration with existing pathways, patient awareness campaigns, and sustained investment in training and quality assurance. International experience from countries that have deployed rapid endometriosis diagnostics suggests that coordinated rollout, with clear referral protocols and feedback mechanisms, yields the most equitable outcomes.
What this means
Women with suspected endometriosis can expect faster diagnostic confirmation and earlier access to treatment, reducing years of pain, uncertainty, and untreated disease. Those seeking fertility preservation may benefit from earlier intervention.
General practitioners and gynaecologists will have more accessible diagnostic tools to confirm endometriosis earlier in the care pathway, enabling evidence-based treatment initiation without prolonged diagnostic limbo. Integration with existing protocols will be key to adoption.
This investment addresses a long-standing diagnostic gap in women’s health and aligns with efforts to reduce health inequalities. Success metrics should include diagnostic turnaround time, treatment initiation rates, and equitable access across all NHS regions.
Frequently asked questions
How long do the new endometriosis tests take?
While the NHS has not specified exact turnaround times, rapid diagnostic tests typically provide results within 1–4 weeks, compared to the current 7–10 year average diagnostic delay in the UK. Exact timing will depend on the specific tests deployed and local laboratory capacity.
Will these tests replace laparoscopy?
The new rapid tests are designed to confirm endometriosis non-invasively, potentially reducing the need for laparoscopic surgery as a diagnostic procedure. However, laparoscopy may still be recommended for classification of disease severity or in cases where diagnosis remains uncertain. Clinical protocols will evolve as these tests are integrated into practice.
Who can access these tests on the NHS?
The tests will be available through NHS general practice and hospital referral pathways. Exact eligibility criteria and rollout timelines have not yet been publicly detailed. Patients should discuss suspected endometriosis with their GP to access testing as local services become available.
The introduction of rapid endometriosis diagnostics on the NHS marks a significant step toward addressing a long-neglected health equity gap. With millions of UK women currently living through years of diagnostic delay, these tools offer the potential to transform care pathways and improve quality of life for a vulnerable population. Implementation success will depend on sustained clinical and organisational support, but the signal is clear: endometriosis diagnosis in the UK is entering a new era.
Source: BBC News: ‘Endometriosis tests would have given me years back’
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
